Cardiac Rhythm Management Devices: World Market Outlook 2011-2021
Report Details
How will the cardiac rhythm management devices market perform from 2011? Our new report shows you potential sales and trends to 2021, discussing opportunities and prospects.
Discover sales for implantable cardioverter defibrillator devices, pacemakers, cardiac resynchronisation therapy devices and cardiac ablation market at segment and national levels. Our report gives you business research, analysis and data.
See sales predictions and discussions for implantable cardioverter defibrillator devices, pacemakers, cardiac resynchronisation therapy devices and cardiac ablation. Discover opportunities in these markets. Find data you need in our report.
Discover the activities shaping the development of cardiac rhythm management devices market. Through our research and analysis we aim to save you time and help in your decisions.
The market will change with the launch of new products such as devices suitable for use with MRI and biological pacemakers. Find R&D trends and commercial opportunities there.
Assess companies such as Medtronic, Boston Scientific and St. Jude Medical.
Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.
Detailed analysis of the global Cardiac Rhythm Management Devices Market
Cardiac Rhythm Management Devices: World Market Outlook 2011-2021 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses, opinions from our survey and a review of companies. Discover over 100 tables and charts and two research interviews (shown in the accompanying lists).
Why you should buy Cardiac Rhythm Management Devices: World Market Outlook 2011-2021
In this report, you will receive the following benefits in particular:
You can order this report today
Our report is for everybody needing industry and market analysis for cardiac rhythm management devices. Find trends and answers. Avoid missing out - please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
How will the cardiac rhythm management devices market perform from 2011? Our new report shows you potential sales and trends to 2021, discussing opportunities and prospects.
Discover sales for implantable cardioverter defibrillator devices, pacemakers, cardiac resynchronisation therapy devices and cardiac ablation market at segment and national levels. Our report gives you business research, analysis and data.
See sales predictions and discussions for implantable cardioverter defibrillator devices, pacemakers, cardiac resynchronisation therapy devices and cardiac ablation. Discover opportunities in these markets. Find data you need in our report.
Discover the activities shaping the development of cardiac rhythm management devices market. Through our research and analysis we aim to save you time and help in your decisions.
The market will change with the launch of new products such as devices suitable for use with MRI and biological pacemakers. Find R&D trends and commercial opportunities there.
Assess companies such as Medtronic, Boston Scientific and St. Jude Medical.
Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.
Detailed analysis of the global Cardiac Rhythm Management Devices Market
Cardiac Rhythm Management Devices: World Market Outlook 2011-2021 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses, opinions from our survey and a review of companies. Discover over 100 tables and charts and two research interviews (shown in the accompanying lists).
Why you should buy Cardiac Rhythm Management Devices: World Market Outlook 2011-2021
In this report, you will receive the following benefits in particular:
- You will receive our assessment of the current market for cardiac rhythm management devices, with respect to the leading segments, products, companies and national markets
- You will discover sales trends for the overall cardiac rhythm management devices market from 2011 to 2021 - seeing where commercial growth will occur
- You will discover sales trends for the main segments - implantable cardioverter defibrillator, pacemaker, cardiac resynchronisation therapy and cardiac ablation - from 2011 to 2021, with detailed discussions of market potential
- You will receive sales forecasts for leading geographical markets (US, Japan, Germany, France, Italy, Spain, UK, China and India), with informed discussion
- You will assess leading manufacturers in the cardiac rhythm management devices market
- You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the cardiac rhythm management devices market from 2011 onwards
- You will be able to investigate competition and opportunities influencing the cardiac rhythm management devices market from 2011 onwards
- You will see what will stimulate and restrain the market from 2011
- You will discover the unmet needs in the market, driving the growth from 2011 onwards
- You will view expert opinion from our survey, including full interview transcripts.
You can order this report today
Our report is for everybody needing industry and market analysis for cardiac rhythm management devices. Find trends and answers. Avoid missing out - please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. EXECUTIVE SUMMARY
1.1 Cardiac Rhythm Management Devices Market Highlights
1.2 Overview of Chapter Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Relating to Cardiac Rhythm Management Devices
2. INTRODUCTION
2.1 Cardiac Rhythm Management Definition
2.2 The Heart
2.3 Cardiac Rhythm Disorders
2.3.1 Heart Failure
2.3.2 Arrhythmias
2.3.2.1 Tachycardia
2.3.2.2 Bradycardia
2.4 Cardiac Rhythm Management Devices
2.4.1 Pacemakers
2.4.1.1 History of Pacemakers
2.4.2 Implantable Cardioverter Defibrillators (ICD)
2.4.2.1 History of ICD Devices
2.4.3 Cardiac Resynchronisation Therapy (CRT)
2.4.4 Cardiac Ablation Devices
2.5 Regulation of Cardiac Rhythm Management Devices
2.5.1 The US Regulation System
2.5.2 The European Regulation System
2.5.2.1 Post Marketing Surveillance in the EU
3. THE GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, 2010-2021
3.1 Cardiac Rhythm Management Devices: Market Overview
3.1.1 The Cardiac Rhythm Management Devices Market in 2010
3.2 Regional Market Breakdown, 2010
3.2.1 The US and Japanese Markets
3.2.2 The European Market
3.2.3 The Chinese and Indian Markets
3.3 Global Cardiac Rhythm Management Devices Market Forecast, 2011-2015
3.4 Global Cardiac Rhythm Management Devices Market Forecast, 2015-2021
3.5 Leading Regional Markets for Cardiac Rhythm Management Devices, 2011-2021
3.5.1 The US, European and Japanese Markets, 2011-2021
3.5.1.1 The US Market
3.5.1.2 The European Markets
3.5.1.3 The Japanese Market
3.5.2 The Chinese and Indian Markets, 2011-2021
3.5.2.1 The Chinese Market
3.5.2.2 The Indian Market
4. THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET, 2010-2021
4.1 Chapter Overview
4.2 Leading Companies in the Defibrillator Market, 2010
4.3 The ICD Market in 2010
4.3.1 Regional Breakdown of the ICD Market
4.3.2 Leading Products in the ICD Market, 2010
4.4 The ICD Market Forecast, 2011-2021
4.4.1 The ICD Market Forecast, 2011-2015
4.4.2 The ICD Market Forecast, 2015-2021
4.5 The ICD Market Pipeline
4.5.1 AnalyST Accel ICD (St. Jude Medical)
4.5.2 Paradym RF (Sorin Group)
4.5.3 PICD- Percutaneous Implantable Cardioverter Defibrillator (InnerPulse)
4.5.4 S-ICD System (Cameron Health)
4.5.5 Other Devices
4.5.6 Remote Monitoring
4.6 SWOT Analysis of the ICD Market, 2011-2021
4.6.1 Strengths
4.6.1.1 ICD Devices are More Effective than Anti-Arrhythmia Drugs
4.6.1.2 Continuous Innovation in the Industry
4.6.2 Weaknesses
4.6.2.1 Safety Concerns Regarding ICD Devices
4.6.2.2 Longevity of Devices
4.6.3 Opportunities
4.6.3.1 Aging Population will Lead to an Increased Patient Base
4.6.3.2 Increasing Use of ICD Devices as Prophylactics
4.6.3.3 Emerging Markets Offer Growth Opportunities
4.6.4 Threats
4.6.4.1 Only a Small Number of Companies Operate in The Largest CRM Devices Market
4.6.4.2 Anti Arrhythmia Drugs May Become More Effective
5. THE PACEMAKER MARKET, 2010-2021
5.1 Chapter Overview
5.2 Medtronic Dominates the Pacing Devices Market
5.3 The Pacemaker Market in 2010
5.3.1 Dual-Chamber Pacemakers Dominate the Market in 2010
5.3.2 Regional Breakdown of the Pacemaker Market
5.3.3 Leading Products in the Pacemaker Market
5.4 The Pacemaker Market Forecast, 2011-2021
5.5 The Pacemaker Market Segments, 2010-2021
5.5.1 The Dual-Chamber Pacemaker Market, 2010
5.5.1.1 The Dual-Chamber Pacemaker Market, 2011-2015
5.5.1.2 The Dual-Chamber Pacemaker Market, 2015-2021
5.5.2 The Single Chamber Pacemaker Market, 2010
5.5.2.1 The Single Chamber Pacemaker Market, 2011-2021
5.5.3 The External Pacemaker Market, 2010
5.5.3.1 The External Pacemaker Market, 2011-2021
5.6 The Pacemaker Pipeline
5.6.1 Evia ProMRI Pacemaker Series (BioTronik)
5.6.2 Revo MRI SureScan (Medtronic)
5.6.3 Leadless Pacemakers (Medtronic)
5.6.4 Accent MRI Pacemaker (St. Jude Medical)
5.6.5 SOPHOS 455 (Medico)
5.6.6 Biological Pacemakers (UC Davis)
5.6.7 Stem Cells for the Treatment of Arrhythmias
5.7 SWOT Analysis of the Pacemaker Market, 2011-2021
5.7.1 Strengths
5.7.1.1 Pacemakers are Proven to Save Lives
5.7.1.2 Mature Segment of the Market
5.7.2 Weaknesses
5.7.2.1 Safety Concerns Regarding Pacemakers
5.7.2.2 Longevity of Pacemakers
5.7.3 Opportunities
5.7.3.1 Aging Population Will Increase the Number of Patients Requiring Pacemakers
5.7.3.2 Emerging Economies Will Drive Growth
5.7.4 Threats
5.7.4.1 Only a Small Number of Companies Operate in the Market
5.7.4.2 Biologics and Stem Cells May Become More Important than Artificial Pacemakers
6. THE CARDIAC RESYNCHRONISATION THERAPY DEVICES (CRT) MARKET, 2010-2021
6.1 Chapter Overview
6.2 The Cardiac Resynchronisation Therapy Market in 2010
6.2.1 Leading Segments in the CRT Market
6.2.2 Leading Products and Companies in the CRT Market
6.3 Cardiac Resynchronisation Therapy Market Forecast, 2011-2021
6.3.1 Cardiac Resynchronisation Therapy Market Forecast, 2011-2015
6.3.2 The Cardiac Resynchronisation Therapy Market Forecast, 2015-2021
6.4 Cardiac Resynchronisation Therapy Pipeline, 2011
6.4.1 Consulta CRT-P (Medtronic)
6.4.2 Optimizer III (Impulse Dynamics)
6.4.3 Unify QUADRA (St. Jude Medical)
6.4.4 SonR System (Sorin Group)
6.5 SWOT Analysis of the Cardiac Resynchronisation Therapy Market, 2011-2021
6.5.1 Strengths
6.5.1.1 CRT has a Broad Range of Indications
6.5.1.2 Combination Products Offer Wider Potential Market
6.5.2 Weaknesses
6.5.2.1 Safety Concerns Surrounding CRT
6.5.2.2 Longevity of Devices
6.5.2.3 Low Awareness of Technology in Emerging Economies
6.5.3 Opportunities
6.5.3.1 Aging Population Will Increase the Target Population for CRT Devices
6.5.3.2 Positive Trial Data Will Help to Stimulate Growth
6.5.4 Threats
6.5.4.1 Drugs May Become More Important Than CRT Devices
7. THE CARDIAC ABLATION DEVICES MARKET, 2010-2021
7.1 Chapter Overview
7.2 The Cardiac Ablation Devices Market in 2010
7.2.1 The US was the Largest Market for Cardiac Ablation in 2010
7.2.2 Leading Products in the Cardiac Ablation Market
7.3 Cardiac Ablation Market Forecast, 2011-2021
7.3.1 Cardiac Ablation Market Forecast 2011-2015
7.3.2 The Cardiac Ablation Market Forecast, 2015-2021
7.4 The Cardiac Ablation Pipeline
7.4.1 HeartLight Endoscopic Ablation System (CardioFocus)
7.4.2 The Bard HD Mesh Ablator Catheter (C.R. Bard Electrophysiology)
7.4.3 High Intensity Focused Ultrasound (HIFU) Ablation (ProRhythm)
7.4.4 ATRILAZE Surgical Ablation System (MedicalCV)
7.4.5 Cardiac Ablation Visualisation System (Endosense & Siemens Healthcare)
7.5 SWOT Analysis of the Cardiac Ablation Market
7.5.1 Strengths
7.5.1.1 Current Ablation Therapies are More Effective Than Predecessors
7.5.1.2 Continuous Innovation in the Industry
7.5.1.3 Products Available Now Are Unlikely to Be Market Leaders in Ten Years
7.5.2 Weaknesses
7.5.2.1 Increasing Consolidation in the Market Creating Entry Barriers
7.5.2.2 High Barriers to Entry Threaten to Stifle Innovation
7.5.3 Opportunities
7.5.3.1 Increasing Prevalence of Atrial Fibrillation
7.5.3.2 Emerging Markets Offer Significant Opportunity for Growth
7.5.4 Threats
7.5.4.1 Drugs May Become More Important Than the Ablation Procedure
8. LEADING COMPANIES IN THE CARDIAC RHYTHM MANAGEMENT MARKET, 2010
8.1 Boston Scientific
8.1.1 Boston Scientific Sales, 2010
8.1.2 Boston Scientific's Cardiac Rhythm Management Sales, 2010
8.1.3 Boston Scientific Cardiac Rhythm Management Devices Rankings, 2010
8.1.4 Boston Scientific Pipeline
8.2 Medtronic
8.2.1 Medtronic Sales, 2010
8.2.2 Medtronic Cardiac Rhythm Management Sales, 2010
8.2.3 Medtronic Cardiac Rhythm Management Rankings, 2010
8.2.4 Medtronic Pipeline, 2010
8.3 St. Jude Medical
8.3.1 St. Jude Medical Sales, 2010
8.3.2 St. Jude Medical Cardiac Rhythm Management Sales, 2010
8.3.2.1 St. Jude Medical Cardiac Ablation Sales, 2010
8.3.3 St. Jude Medical Cardiac Rhythm Management Rankings, 2010
8.3.4 St. Jude Medical Pipeline
8.4 Other Companies in the Cardiac Rhythm Management Market
9. EXPERT OPINIONS
9.1 Dr. Gideon Meiry, Former CTO, Odem Medical
9.1.1 The CRT Market
9.1.2 The Future of the CRT Market
9.1.3 Remote Monitoring
9.2 Dr. Mauro Biffi, Senior Electrophysiologist, University of Bologna
9.2.1 The CRM Market
9.2.2 The Future of the CRM Market
9.2.3 Remote Monitoring
10. CONCLUSIONS
10.1 The Cardiac Rhythm Management Devices Market, 2010-2021
10.1.1 Growth Will be Driven by Emerging Markets
10.2 The Implantable Cardioverter Defibrillator Market, 2010-2021
10.3 The Pacemaker Market, 2010-2021
10.4 The Cardiac Resynchronisation Therapy Market, 2010-2021
10.5 The Cardiac Ablation Devices Market, 2010-2021
Appendix A
Appendix B
Visiongain report evaluation form
1.1 Cardiac Rhythm Management Devices Market Highlights
1.2 Overview of Chapter Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Relating to Cardiac Rhythm Management Devices
2. INTRODUCTION
2.1 Cardiac Rhythm Management Definition
2.2 The Heart
2.3 Cardiac Rhythm Disorders
2.3.1 Heart Failure
2.3.2 Arrhythmias
2.3.2.1 Tachycardia
2.3.2.2 Bradycardia
2.4 Cardiac Rhythm Management Devices
2.4.1 Pacemakers
2.4.1.1 History of Pacemakers
2.4.2 Implantable Cardioverter Defibrillators (ICD)
2.4.2.1 History of ICD Devices
2.4.3 Cardiac Resynchronisation Therapy (CRT)
2.4.4 Cardiac Ablation Devices
2.5 Regulation of Cardiac Rhythm Management Devices
2.5.1 The US Regulation System
2.5.2 The European Regulation System
2.5.2.1 Post Marketing Surveillance in the EU
3. THE GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, 2010-2021
3.1 Cardiac Rhythm Management Devices: Market Overview
3.1.1 The Cardiac Rhythm Management Devices Market in 2010
3.2 Regional Market Breakdown, 2010
3.2.1 The US and Japanese Markets
3.2.2 The European Market
3.2.3 The Chinese and Indian Markets
3.3 Global Cardiac Rhythm Management Devices Market Forecast, 2011-2015
3.4 Global Cardiac Rhythm Management Devices Market Forecast, 2015-2021
3.5 Leading Regional Markets for Cardiac Rhythm Management Devices, 2011-2021
3.5.1 The US, European and Japanese Markets, 2011-2021
3.5.1.1 The US Market
3.5.1.2 The European Markets
3.5.1.3 The Japanese Market
3.5.2 The Chinese and Indian Markets, 2011-2021
3.5.2.1 The Chinese Market
3.5.2.2 The Indian Market
4. THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET, 2010-2021
4.1 Chapter Overview
4.2 Leading Companies in the Defibrillator Market, 2010
4.3 The ICD Market in 2010
4.3.1 Regional Breakdown of the ICD Market
4.3.2 Leading Products in the ICD Market, 2010
4.4 The ICD Market Forecast, 2011-2021
4.4.1 The ICD Market Forecast, 2011-2015
4.4.2 The ICD Market Forecast, 2015-2021
4.5 The ICD Market Pipeline
4.5.1 AnalyST Accel ICD (St. Jude Medical)
4.5.2 Paradym RF (Sorin Group)
4.5.3 PICD- Percutaneous Implantable Cardioverter Defibrillator (InnerPulse)
4.5.4 S-ICD System (Cameron Health)
4.5.5 Other Devices
4.5.6 Remote Monitoring
4.6 SWOT Analysis of the ICD Market, 2011-2021
4.6.1 Strengths
4.6.1.1 ICD Devices are More Effective than Anti-Arrhythmia Drugs
4.6.1.2 Continuous Innovation in the Industry
4.6.2 Weaknesses
4.6.2.1 Safety Concerns Regarding ICD Devices
4.6.2.2 Longevity of Devices
4.6.3 Opportunities
4.6.3.1 Aging Population will Lead to an Increased Patient Base
4.6.3.2 Increasing Use of ICD Devices as Prophylactics
4.6.3.3 Emerging Markets Offer Growth Opportunities
4.6.4 Threats
4.6.4.1 Only a Small Number of Companies Operate in The Largest CRM Devices Market
4.6.4.2 Anti Arrhythmia Drugs May Become More Effective
5. THE PACEMAKER MARKET, 2010-2021
5.1 Chapter Overview
5.2 Medtronic Dominates the Pacing Devices Market
5.3 The Pacemaker Market in 2010
5.3.1 Dual-Chamber Pacemakers Dominate the Market in 2010
5.3.2 Regional Breakdown of the Pacemaker Market
5.3.3 Leading Products in the Pacemaker Market
5.4 The Pacemaker Market Forecast, 2011-2021
5.5 The Pacemaker Market Segments, 2010-2021
5.5.1 The Dual-Chamber Pacemaker Market, 2010
5.5.1.1 The Dual-Chamber Pacemaker Market, 2011-2015
5.5.1.2 The Dual-Chamber Pacemaker Market, 2015-2021
5.5.2 The Single Chamber Pacemaker Market, 2010
5.5.2.1 The Single Chamber Pacemaker Market, 2011-2021
5.5.3 The External Pacemaker Market, 2010
5.5.3.1 The External Pacemaker Market, 2011-2021
5.6 The Pacemaker Pipeline
5.6.1 Evia ProMRI Pacemaker Series (BioTronik)
5.6.2 Revo MRI SureScan (Medtronic)
5.6.3 Leadless Pacemakers (Medtronic)
5.6.4 Accent MRI Pacemaker (St. Jude Medical)
5.6.5 SOPHOS 455 (Medico)
5.6.6 Biological Pacemakers (UC Davis)
5.6.7 Stem Cells for the Treatment of Arrhythmias
5.7 SWOT Analysis of the Pacemaker Market, 2011-2021
5.7.1 Strengths
5.7.1.1 Pacemakers are Proven to Save Lives
5.7.1.2 Mature Segment of the Market
5.7.2 Weaknesses
5.7.2.1 Safety Concerns Regarding Pacemakers
5.7.2.2 Longevity of Pacemakers
5.7.3 Opportunities
5.7.3.1 Aging Population Will Increase the Number of Patients Requiring Pacemakers
5.7.3.2 Emerging Economies Will Drive Growth
5.7.4 Threats
5.7.4.1 Only a Small Number of Companies Operate in the Market
5.7.4.2 Biologics and Stem Cells May Become More Important than Artificial Pacemakers
6. THE CARDIAC RESYNCHRONISATION THERAPY DEVICES (CRT) MARKET, 2010-2021
6.1 Chapter Overview
6.2 The Cardiac Resynchronisation Therapy Market in 2010
6.2.1 Leading Segments in the CRT Market
6.2.2 Leading Products and Companies in the CRT Market
6.3 Cardiac Resynchronisation Therapy Market Forecast, 2011-2021
6.3.1 Cardiac Resynchronisation Therapy Market Forecast, 2011-2015
6.3.2 The Cardiac Resynchronisation Therapy Market Forecast, 2015-2021
6.4 Cardiac Resynchronisation Therapy Pipeline, 2011
6.4.1 Consulta CRT-P (Medtronic)
6.4.2 Optimizer III (Impulse Dynamics)
6.4.3 Unify QUADRA (St. Jude Medical)
6.4.4 SonR System (Sorin Group)
6.5 SWOT Analysis of the Cardiac Resynchronisation Therapy Market, 2011-2021
6.5.1 Strengths
6.5.1.1 CRT has a Broad Range of Indications
6.5.1.2 Combination Products Offer Wider Potential Market
6.5.2 Weaknesses
6.5.2.1 Safety Concerns Surrounding CRT
6.5.2.2 Longevity of Devices
6.5.2.3 Low Awareness of Technology in Emerging Economies
6.5.3 Opportunities
6.5.3.1 Aging Population Will Increase the Target Population for CRT Devices
6.5.3.2 Positive Trial Data Will Help to Stimulate Growth
6.5.4 Threats
6.5.4.1 Drugs May Become More Important Than CRT Devices
7. THE CARDIAC ABLATION DEVICES MARKET, 2010-2021
7.1 Chapter Overview
7.2 The Cardiac Ablation Devices Market in 2010
7.2.1 The US was the Largest Market for Cardiac Ablation in 2010
7.2.2 Leading Products in the Cardiac Ablation Market
7.3 Cardiac Ablation Market Forecast, 2011-2021
7.3.1 Cardiac Ablation Market Forecast 2011-2015
7.3.2 The Cardiac Ablation Market Forecast, 2015-2021
7.4 The Cardiac Ablation Pipeline
7.4.1 HeartLight Endoscopic Ablation System (CardioFocus)
7.4.2 The Bard HD Mesh Ablator Catheter (C.R. Bard Electrophysiology)
7.4.3 High Intensity Focused Ultrasound (HIFU) Ablation (ProRhythm)
7.4.4 ATRILAZE Surgical Ablation System (MedicalCV)
7.4.5 Cardiac Ablation Visualisation System (Endosense & Siemens Healthcare)
7.5 SWOT Analysis of the Cardiac Ablation Market
7.5.1 Strengths
7.5.1.1 Current Ablation Therapies are More Effective Than Predecessors
7.5.1.2 Continuous Innovation in the Industry
7.5.1.3 Products Available Now Are Unlikely to Be Market Leaders in Ten Years
7.5.2 Weaknesses
7.5.2.1 Increasing Consolidation in the Market Creating Entry Barriers
7.5.2.2 High Barriers to Entry Threaten to Stifle Innovation
7.5.3 Opportunities
7.5.3.1 Increasing Prevalence of Atrial Fibrillation
7.5.3.2 Emerging Markets Offer Significant Opportunity for Growth
7.5.4 Threats
7.5.4.1 Drugs May Become More Important Than the Ablation Procedure
8. LEADING COMPANIES IN THE CARDIAC RHYTHM MANAGEMENT MARKET, 2010
8.1 Boston Scientific
8.1.1 Boston Scientific Sales, 2010
8.1.2 Boston Scientific's Cardiac Rhythm Management Sales, 2010
8.1.3 Boston Scientific Cardiac Rhythm Management Devices Rankings, 2010
8.1.4 Boston Scientific Pipeline
8.2 Medtronic
8.2.1 Medtronic Sales, 2010
8.2.2 Medtronic Cardiac Rhythm Management Sales, 2010
8.2.3 Medtronic Cardiac Rhythm Management Rankings, 2010
8.2.4 Medtronic Pipeline, 2010
8.3 St. Jude Medical
8.3.1 St. Jude Medical Sales, 2010
8.3.2 St. Jude Medical Cardiac Rhythm Management Sales, 2010
8.3.2.1 St. Jude Medical Cardiac Ablation Sales, 2010
8.3.3 St. Jude Medical Cardiac Rhythm Management Rankings, 2010
8.3.4 St. Jude Medical Pipeline
8.4 Other Companies in the Cardiac Rhythm Management Market
9. EXPERT OPINIONS
9.1 Dr. Gideon Meiry, Former CTO, Odem Medical
9.1.1 The CRT Market
9.1.2 The Future of the CRT Market
9.1.3 Remote Monitoring
9.2 Dr. Mauro Biffi, Senior Electrophysiologist, University of Bologna
9.2.1 The CRM Market
9.2.2 The Future of the CRM Market
9.2.3 Remote Monitoring
10. CONCLUSIONS
10.1 The Cardiac Rhythm Management Devices Market, 2010-2021
10.1.1 Growth Will be Driven by Emerging Markets
10.2 The Implantable Cardioverter Defibrillator Market, 2010-2021
10.3 The Pacemaker Market, 2010-2021
10.4 The Cardiac Resynchronisation Therapy Market, 2010-2021
10.5 The Cardiac Ablation Devices Market, 2010-2021
Appendix A
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 2.1 The Cardiology Device Market ($bn) by Segment, 2010
Table 2.2 New York Heart Association Functional Classification System
Table 2.3 Common Methods Used to Diagnose CHF
Table 2.4 Management Options for Patients with Heart Failure
Table 2.5 Risk Factors for Developing Arrhythmias
Table 2.6 Treatment Options for Patient Suffering From Arrhythmias
Table 2.7 The Advantages and Disadvantages of Cardiac Resynchronisation Therapy (CRT)
Table 3.1 The Cardiac Rhythm Management Devices Market ($bn) by Segment, 2010
Table 3.2 Leading National Markets for Cardiac Rhythm Management Devices ($bn), 2010
Table 3.3 The Global Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2021
Table 3.4 Leading Cardiac Rhythm Management Devices Regional Market Forecasts ($bn), 2010-2015
Table 3.5 Leading Cardiac Rhythm Management Devices Regional Market Forecasts ($bn), 2015-2021
Table 3.6 Chinese Cardiac Rhythm Management Devices Market: Drivers and Restraints, 2011-2021
Table 4.1 Leading Companies in the Defibrillator Market by Sales ($bn), 2010
Table 4.2 The ICD Market ($bn) by Region/ Country, 2010
Table 4.3 Leading Products in the ICD Market, 2010
Table 4.4 The ICD Market Forecast ($bn), 2010-2015
Table 4.5 The ICD Market Forecast ($bn), 2015-2021
Table 4.6 The ICD Development Pipeline, 2011
Table 4.7 SWOT Analysis of the ICD Market, 2011-2021
Table 5.1 Leading Companies in the Pacing Devices Market by Sales ($bn) and Market Share (%), 2010
Table 5.2 The Pacemaker Market ($bn) by Segment, 2010
Table 5.3 The Pacemaker Market ($bn) by Region/ Country, 2010
Table 5.4 Leading Products in the Pacemaker Market, 2010
Table 5.5 The Pacemaker Market Forecast ($bn), 2010-2021
Table 5.6 The Dual-Chamber Pacemaker Market Forecast ($bn), 2010-2015
Table 5.7 The Dual-Chamber Pacemaker Market Forecast ($bn), 2015-2021
Table 5.8 The Single Chamber Pacemaker Market Forecast ($bn), 2010-2021
Table 5.9 The External Pacemaker Market Forecast ($bn), 2010-2021
Table 5.10 Pacemaker Development Pipeline, 2011
Table 5.11 SWOT Analysis of the Pacemaker Market, 2011-2021
Table 6.1 The Cardiac Resynchronisation Therapy Market ($bn) by Segment, 2010
Table 6.2 Leading Products in the Cardiac Resynchronisation Market, 2010
Table 6.3 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2010-2015
Table 6.4 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2015-2021
Table 6.5 Cardiac Resynchronisation Development Pipeline, 2011
Table 6.6 SWOT Analysis of the Cardiac Resynchronisation Therapy Market, 2011-2021
Table 7.1 The Cardiac Ablation Market ($m) by Region/Country, 2010
Table 7.2 The Leading Products in the Cardiac Ablation Market, 2010
Table 7.3 The Cardiac Ablation Market Forecast ($m), 2010-2015
Table 7.4 The Cardiac Ablation Market Forecast ($m), 2015-2021
Table 7.5 The Cardiac Ablation Pipeline, 2011
Table 7.6 SWOT Analysis of The Cardiac Ablation Market, 2011-2021
Table 8.1 Boston Scientific Sales ($bn) by Business Segment, 2010
Table 8.2 Boston Scientific CRM Segment Sales ($m), 2009 and 2010
Table 8.3 Boston Scientific Rankings by Sales, 2010
Table 8.4 Medtronic Sales ($m) by Business Segment, 2009 and 2010
Table 8.5 Medtronic CRDM Sales ($m), 2010
Table 8.6 Medtronic Sales ($bn) by Region, 2010
Table 8.7 Medtronic Rankings by Sales, 2010
Table 8.8 St. Jude Medical Sales ($m) by Business Segment, 2010
Table 8.9 St. Jude Medical CRM Segment Sales ($m), 2010
Table 8.10 St. Jude Medical Rankings by Sales, 2010
Table 8.11 Other Companies in the Cardiac Rhythm Management Market, 2011
Table 2.1 The Cardiology Device Market ($bn) by Segment, 2010
Table 2.2 New York Heart Association Functional Classification System
Table 2.3 Common Methods Used to Diagnose CHF
Table 2.4 Management Options for Patients with Heart Failure
Table 2.5 Risk Factors for Developing Arrhythmias
Table 2.6 Treatment Options for Patient Suffering From Arrhythmias
Table 2.7 The Advantages and Disadvantages of Cardiac Resynchronisation Therapy (CRT)
Table 3.1 The Cardiac Rhythm Management Devices Market ($bn) by Segment, 2010
Table 3.2 Leading National Markets for Cardiac Rhythm Management Devices ($bn), 2010
Table 3.3 The Global Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2021
Table 3.4 Leading Cardiac Rhythm Management Devices Regional Market Forecasts ($bn), 2010-2015
Table 3.5 Leading Cardiac Rhythm Management Devices Regional Market Forecasts ($bn), 2015-2021
Table 3.6 Chinese Cardiac Rhythm Management Devices Market: Drivers and Restraints, 2011-2021
Table 4.1 Leading Companies in the Defibrillator Market by Sales ($bn), 2010
Table 4.2 The ICD Market ($bn) by Region/ Country, 2010
Table 4.3 Leading Products in the ICD Market, 2010
Table 4.4 The ICD Market Forecast ($bn), 2010-2015
Table 4.5 The ICD Market Forecast ($bn), 2015-2021
Table 4.6 The ICD Development Pipeline, 2011
Table 4.7 SWOT Analysis of the ICD Market, 2011-2021
Table 5.1 Leading Companies in the Pacing Devices Market by Sales ($bn) and Market Share (%), 2010
Table 5.2 The Pacemaker Market ($bn) by Segment, 2010
Table 5.3 The Pacemaker Market ($bn) by Region/ Country, 2010
Table 5.4 Leading Products in the Pacemaker Market, 2010
Table 5.5 The Pacemaker Market Forecast ($bn), 2010-2021
Table 5.6 The Dual-Chamber Pacemaker Market Forecast ($bn), 2010-2015
Table 5.7 The Dual-Chamber Pacemaker Market Forecast ($bn), 2015-2021
Table 5.8 The Single Chamber Pacemaker Market Forecast ($bn), 2010-2021
Table 5.9 The External Pacemaker Market Forecast ($bn), 2010-2021
Table 5.10 Pacemaker Development Pipeline, 2011
Table 5.11 SWOT Analysis of the Pacemaker Market, 2011-2021
Table 6.1 The Cardiac Resynchronisation Therapy Market ($bn) by Segment, 2010
Table 6.2 Leading Products in the Cardiac Resynchronisation Market, 2010
Table 6.3 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2010-2015
Table 6.4 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2015-2021
Table 6.5 Cardiac Resynchronisation Development Pipeline, 2011
Table 6.6 SWOT Analysis of the Cardiac Resynchronisation Therapy Market, 2011-2021
Table 7.1 The Cardiac Ablation Market ($m) by Region/Country, 2010
Table 7.2 The Leading Products in the Cardiac Ablation Market, 2010
Table 7.3 The Cardiac Ablation Market Forecast ($m), 2010-2015
Table 7.4 The Cardiac Ablation Market Forecast ($m), 2015-2021
Table 7.5 The Cardiac Ablation Pipeline, 2011
Table 7.6 SWOT Analysis of The Cardiac Ablation Market, 2011-2021
Table 8.1 Boston Scientific Sales ($bn) by Business Segment, 2010
Table 8.2 Boston Scientific CRM Segment Sales ($m), 2009 and 2010
Table 8.3 Boston Scientific Rankings by Sales, 2010
Table 8.4 Medtronic Sales ($m) by Business Segment, 2009 and 2010
Table 8.5 Medtronic CRDM Sales ($m), 2010
Table 8.6 Medtronic Sales ($bn) by Region, 2010
Table 8.7 Medtronic Rankings by Sales, 2010
Table 8.8 St. Jude Medical Sales ($m) by Business Segment, 2010
Table 8.9 St. Jude Medical CRM Segment Sales ($m), 2010
Table 8.10 St. Jude Medical Rankings by Sales, 2010
Table 8.11 Other Companies in the Cardiac Rhythm Management Market, 2011
LIST OF FIGURES
Figure 2.1 Market Shares (%) of the Leading Segments in the Cardiology Device Market, 2010
Figure 2.2 Sales ($bn) of Leading Segments in the Cardiology Device Market, 2010
Figure 2.3 The Exterior of The Human Heart
Figure 2.4 The Interior of The Human Heart
Figure 2.5 The Conducting System of The Human Heart
Figure 2.6 The Timeline of Important Developments in the History of Pacemakers
Figure 3.1 The Cardiac Rhythm Management Devices Market Share (%) by Segment, 2010
Figure 3.2 The Cardiac Rhythm Management Devices Market ($bn) by Segment, 2010
Figure 3.3 Leading National Market Shares (%) in the Cardiac Rhythm Management Devices Market, 2010
Figure 3.4 Leading National Markets ($bn) in the Cardiac Rhythm Management Devices Market, 2010
Figure 3.5 The Global Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2021
Figure 3.6 The US Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2015
Figure 3.7 The European Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2015
Figure 3.8 The Asian Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2015
Figure 3.9 The US Cardiac Rhythm Management Devices Market Forecast ($bn), 2015-2021
Figure 3.10 The European Cardiac Rhythm Management Devices Market Forecast ($bn), 2015-2021
Figure 3.11 The Asian Cardiac Rhythm Management Devices Market Forecast ($bn), 2015-2021
Figure 4.1 Market Share (%) of Leading Companies in the Defibrillator Market, 2010
Figure 4.2 Sales ($bn) of Leading Companies in the Defibrillator Market, 2010
Figure 4.3 The ICD Market Share (%) by Region/Country, 2010
Figure 4.4 The ICD Market ($bn) by Region/Country, 2010
Figure 4.5 The ICD Market Forecast ($bn), 2010-2015
Figure 4.6 The ICD Market Forecast ($bn), 2015-2021
Figure 4.7 The Remote Monitoring Network for ICD Devices
Figure 5.1 Market Share (%) of Leading Companies in the Pacing Devices Market, 2010
Figure 5.2 Market Share (%) of Leading Segments in the Pacemaker Market, 2010
Figure 5.3 The Pacemaker Market ($bn) by Segment, 2010
Figure 5.4 The Pacemaker Market Share (%) by Region/Country, 2010
Figure 5.5 The Pacemaker Market ($bn) by Region/Country, 2010
Figure 5.6 The Pacemaker Market Forecast ($bn), 2010-2021
Figure 5.7 The Dual-Chamber Pacemaker Market Forecast ($bn), 2010-2015
Figure 5.8 The Dual-Chamber Pacemaker Market Forecast ($bn), 2015-2021
Figure 5.9 The Single Chamber Pacemaker Market Forecast ($bn), 2010-2021
Figure 5.10 The External Pacemaker Market Forecast ($bn), 2010-2021
Figure 6.1 Market Share (%) of Leading Segments in the Cardiac Resynchronisation Therapy Market, 2010
Figure 6.2 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2010-2015
Figure 6.3 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2015-2021
Figure 7.1 The Cardiac Ablation Market Share (%) by Region/Country, 2010
Figure 7.2 The Cardiac Ablation Market ($m) by Region/Country, 2010
Figure 7.3 The Cardiac Ablation Market Forecast ($m), 2010-2015
Figure 7.4 The Cardiac Ablation Market Forecast ($m), 2015-2021
Figure 8.1 Boston Scientific Sales Share (%) by Business Segment, 2010
Figure 8.2 Boston Scientific Sales ($bn) by Business Segment, 2010
Figure 8.3 Boston Scientific CRM Segment Sales ($m), 2009 and 2010
Figure 8.4 Boston Scientific CRM Segment US Sales ($m), 2009 and 2010
Figure 8.5 Boston Scientific CRM Segment International Sales ($m), 2009 and 2010
Figure 8.6 Medtronic Sales ($m) by Business Segment, 2009 and 2010
Figure 8.7 Medtronic Sales Share (%) by Business Segment, 2010
Figure 8.8 Medtronic CRDM Sales Share (%) 2010 by Segment, 2010
Figure 8.9 Medtronic Sales Share (%) by Region, 2010
Figure 8.10 St. Jude Medical Sales Share (%) by Business Segment, 2010
Figure 8.11 St. Jude Medical Sales Share (%) by Business Segment, 2010
Figure 8.12 St. Jude Medical CRM Segment Sales Share (%), 2010
COMPANIES LISTED
3M PHARMACEUTICALS
Abbott Laboratories
Ablation Frontiers
ARCO
Astra Zeneca
AtriCure
ATS Medical
Aventis
Biosense Webster
BioTronik
Boston Scientific
Bristol-Myers Squibb
C.R Bard
C.R Bard Electrophysiology
Cameron Health
CardioFocus
Center for Devices and Radiological Health (CDRH)
CryoCath Technologies
CryoCor
Endosense
European Heart Rhythm Association (EHRA)
FDA's MedWatch
Food and Drug Administration (FDA)
Global Harmonization Task Force
Guidant Corporation
Hansen Medical
Impulse Dynamics
InnerPulse
Japanese Ministry of Health, Labour and Welfare (MHLW)
John Hopkins University Medical School
Johnson & Johnson
Karolinska Institute
MedicalCV
Medico
MediVed
Medtronic
MHRA (Medicines and Healthcare Products Regulatory Agency)
New York Heart Association
Odem Medical
Pfizer
ProRhythm
Rainbow Medical
Shree Pacetronix
Siemens Healthcare
Sinai Hospital, Baltimore
Sorin Group
St. Jude Medical
Stony Brook University
Transurgical
UC Davis
University of Bologna
University of Missouri
US Bankruptcy Court for the District of Delaware
World Society of Arrhythmias
Wyeth
Zoll Medical Corporation
Figure 2.1 Market Shares (%) of the Leading Segments in the Cardiology Device Market, 2010
Figure 2.2 Sales ($bn) of Leading Segments in the Cardiology Device Market, 2010
Figure 2.3 The Exterior of The Human Heart
Figure 2.4 The Interior of The Human Heart
Figure 2.5 The Conducting System of The Human Heart
Figure 2.6 The Timeline of Important Developments in the History of Pacemakers
Figure 3.1 The Cardiac Rhythm Management Devices Market Share (%) by Segment, 2010
Figure 3.2 The Cardiac Rhythm Management Devices Market ($bn) by Segment, 2010
Figure 3.3 Leading National Market Shares (%) in the Cardiac Rhythm Management Devices Market, 2010
Figure 3.4 Leading National Markets ($bn) in the Cardiac Rhythm Management Devices Market, 2010
Figure 3.5 The Global Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2021
Figure 3.6 The US Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2015
Figure 3.7 The European Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2015
Figure 3.8 The Asian Cardiac Rhythm Management Devices Market Forecast ($bn), 2010-2015
Figure 3.9 The US Cardiac Rhythm Management Devices Market Forecast ($bn), 2015-2021
Figure 3.10 The European Cardiac Rhythm Management Devices Market Forecast ($bn), 2015-2021
Figure 3.11 The Asian Cardiac Rhythm Management Devices Market Forecast ($bn), 2015-2021
Figure 4.1 Market Share (%) of Leading Companies in the Defibrillator Market, 2010
Figure 4.2 Sales ($bn) of Leading Companies in the Defibrillator Market, 2010
Figure 4.3 The ICD Market Share (%) by Region/Country, 2010
Figure 4.4 The ICD Market ($bn) by Region/Country, 2010
Figure 4.5 The ICD Market Forecast ($bn), 2010-2015
Figure 4.6 The ICD Market Forecast ($bn), 2015-2021
Figure 4.7 The Remote Monitoring Network for ICD Devices
Figure 5.1 Market Share (%) of Leading Companies in the Pacing Devices Market, 2010
Figure 5.2 Market Share (%) of Leading Segments in the Pacemaker Market, 2010
Figure 5.3 The Pacemaker Market ($bn) by Segment, 2010
Figure 5.4 The Pacemaker Market Share (%) by Region/Country, 2010
Figure 5.5 The Pacemaker Market ($bn) by Region/Country, 2010
Figure 5.6 The Pacemaker Market Forecast ($bn), 2010-2021
Figure 5.7 The Dual-Chamber Pacemaker Market Forecast ($bn), 2010-2015
Figure 5.8 The Dual-Chamber Pacemaker Market Forecast ($bn), 2015-2021
Figure 5.9 The Single Chamber Pacemaker Market Forecast ($bn), 2010-2021
Figure 5.10 The External Pacemaker Market Forecast ($bn), 2010-2021
Figure 6.1 Market Share (%) of Leading Segments in the Cardiac Resynchronisation Therapy Market, 2010
Figure 6.2 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2010-2015
Figure 6.3 The Cardiac Resynchronisation Therapy Market Forecast ($bn), 2015-2021
Figure 7.1 The Cardiac Ablation Market Share (%) by Region/Country, 2010
Figure 7.2 The Cardiac Ablation Market ($m) by Region/Country, 2010
Figure 7.3 The Cardiac Ablation Market Forecast ($m), 2010-2015
Figure 7.4 The Cardiac Ablation Market Forecast ($m), 2015-2021
Figure 8.1 Boston Scientific Sales Share (%) by Business Segment, 2010
Figure 8.2 Boston Scientific Sales ($bn) by Business Segment, 2010
Figure 8.3 Boston Scientific CRM Segment Sales ($m), 2009 and 2010
Figure 8.4 Boston Scientific CRM Segment US Sales ($m), 2009 and 2010
Figure 8.5 Boston Scientific CRM Segment International Sales ($m), 2009 and 2010
Figure 8.6 Medtronic Sales ($m) by Business Segment, 2009 and 2010
Figure 8.7 Medtronic Sales Share (%) by Business Segment, 2010
Figure 8.8 Medtronic CRDM Sales Share (%) 2010 by Segment, 2010
Figure 8.9 Medtronic Sales Share (%) by Region, 2010
Figure 8.10 St. Jude Medical Sales Share (%) by Business Segment, 2010
Figure 8.11 St. Jude Medical Sales Share (%) by Business Segment, 2010
Figure 8.12 St. Jude Medical CRM Segment Sales Share (%), 2010
COMPANIES LISTED
3M PHARMACEUTICALS
Abbott Laboratories
Ablation Frontiers
ARCO
Astra Zeneca
AtriCure
ATS Medical
Aventis
Biosense Webster
BioTronik
Boston Scientific
Bristol-Myers Squibb
C.R Bard
C.R Bard Electrophysiology
Cameron Health
CardioFocus
Center for Devices and Radiological Health (CDRH)
CryoCath Technologies
CryoCor
Endosense
European Heart Rhythm Association (EHRA)
FDA's MedWatch
Food and Drug Administration (FDA)
Global Harmonization Task Force
Guidant Corporation
Hansen Medical
Impulse Dynamics
InnerPulse
Japanese Ministry of Health, Labour and Welfare (MHLW)
John Hopkins University Medical School
Johnson & Johnson
Karolinska Institute
MedicalCV
Medico
MediVed
Medtronic
MHRA (Medicines and Healthcare Products Regulatory Agency)
New York Heart Association
Odem Medical
Pfizer
ProRhythm
Rainbow Medical
Shree Pacetronix
Siemens Healthcare
Sinai Hospital, Baltimore
Sorin Group
St. Jude Medical
Stony Brook University
Transurgical
UC Davis
University of Bologna
University of Missouri
US Bankruptcy Court for the District of Delaware
World Society of Arrhythmias
Wyeth
Zoll Medical Corporation
